Randal Chase

Randal D.
Chase is currently an Independent Director at GeoVax Labs, Inc. since 2015.
Former roles include President & Chief Executive Officer at North American Vaccine, Inc. from 1998 to 2000; President, CEO & Non-Independent Director at Advanced Proteome Therapeutics Corp.
from 2017 to 2018; President & Chief Executive Officer at Immunovaccine Technologies, Inc. from 2007 to 2011; President & Chief Executive Officer at Pasteur Mérieux Connaught from 1995 to 1998; President & Chief Executive Officer at IMV, Inc. from 2006 to 2011; Chairman at Medicago, Inc. from 2003 to 2013; Executive Chairman at Molecular Templates, Inc. from 2005 to 2006; Director at Bioject Medical Technologies, Inc. from 2005 to 2009; Non-Executive Director at Acambis Plc from 2002 to 2008; Director at ConjuChem, Inc. and ConjuChem Biotechnologies, Inc. from 2004 to 2009; Director at Rhino Resources, Inc. (Canada) in 2009; Director at The Bristol-Myers Squibb Canada Co. from 1978 to 1988; President at Shire BioChem, Inc. from 2001 to 2004; Senior Vice President-Vaccines Operations at Biochem Pharma, Inc. from 2001 to 2002; President at Quadralogic Technologies, Inc. from 1993 to 1995; and other director and president roles at various firms.
Education includes a doctorate from the University of British Columbia conferred in 1974 and undergraduate studies at Bishop's University.